News Search Results
Sep 08, 2025, 10:33 ET Liquid Biopsy Market to Reach USD 30.65 Billion by 2035, with CAGR 9.41% Driven by Rising Cancer Burden and Demand for Non-Invasive Diagnostics - Vantage Market Research
Annual Growth Rate) of 12.61% between 2025 and 2035.Synthetic Biology Market: The global Synthetic Biology Market is valued at USD 16.94 Billion in 2024 and is projected
More news about: Vantage Market Research
Aug 26, 2025, 08:34 ET OODAcon 2025: Accelerating Disruptive Technologies
scenario-driven update on the world's most urgent risks.Biotech Warfare and Biosecurity in the Age of AI: Navigating the risks of synthetic biology and dual-use research.Art and Privacy in the Age of AI: Protecting civil liberties and resilience amid ubiquitous surveillance.Moving
More news about: OODA LLC
Aug 21, 2025, 08:30 ET AI in Molecular Biology: Revolutionizing the Future of Biotech, Upcoming Webinar Hosted by Xtalks
simplify research processes in biotechnology and life sciences. Attendees will learn how accelerated innovation facilitates breakthroughs in synthetic biology, drug discovery, gene therapy and other cutting-edge fields. The featured speaker will share how data-driven decisions empower scientists with
More news about: Xtalks
Aug 20, 2025, 10:15 ET Human Microbiome Market worth $7.09 billion by 2031 with 31.0% CAGR | MarketsandMarkets™
different stages of life or health needs. The microbiome innovation of IFF is supported by ongoing collaborations and a broader portfolio in synthetic biology, enabling the development of functional ingredients across consumer and health product categories. For more information,
More news about: MarketsandMarkets
Aug 20, 2025, 08:32 ET Quintara Biosciences Launches Whole Plasmid Sequencing - Express (WPS-Express) Across Four U.S. Sites
length or data quality. Combined with localized logistics support, the service is ideal for fast-paced research settings in molecular cloning, synthetic biology, and antibody discovery. Quintara Biosciences is a nationwide provider of genomics and molecular biology services, offering sequencing,
More news about: Quintara Biosciences
Aug 20, 2025, 08:01 ET Ginkgo Datapoints, Tangible Scientific, and Inductive Bio Partner to Deploy AI-driven Lab-in-the-loop Workflows Across the Biopharma Industry
business opportunities, including with respect to our solutions and tools offerings, (iv) the risk of downturns in demand for products using synthetic biology, (v) the uncertainty regarding the demand for passive monitoring programs and biosecurity services, (vi) changes to the biosecurity industry,
More news about: Ginkgo Bioworks
Aug 17, 2025, 08:01 ET GenScript Biotech Demonstrates Profitable Scale and Strategic Leadership in H1 2025, Establishing Clear Industry Leadership Through Accelerated Growth and Innovation
into future revenue streams and underline long-term growth potential. Industrial synthetic biology products' Market Leadership and Product Innovation Bestzyme, Industrial synthetic biology products unit, grew its revenue by 8.4%, driven by market share gains for its innovative enzyme
More news about: GenScript Biotech Corporation
Aug 12, 2025, 09:00 ET Closed Loop Partners Advances Major Progress for the Circular Economy, With Portfolio Companies Keeping Over $5 Billion of Materials and Products in Circulation Through Local and Regional Investments and Infrastructure Builds
firm, together with its partners, has achieved several milestones, including: 90+ investments in solutions ranging from synthetic biology and regional recycling to advanced material recovery technologies through venture capital, private equity, and catalytic capital & private
More news about: Closed Loop Partners
Aug 12, 2025, 08:01 ET Ginkgo Automation Appoints Brian O'Sullivan as Head of Commercial to Accelerate External Growth
business opportunities, including with respect to our solutions and tools offerings, (iv) the risk of downturns in demand for products using synthetic biology, (v) the uncertainty regarding the demand for passive monitoring programs and biosecurity services, (vi) changes to the biosecurity industry,
More news about: Ginkgo Bioworks
Aug 07, 2025, 17:01 ET Ginkgo Bioworks Reports Second Quarter 2025 Financial Results
business opportunities, including with respect to our solutions and tools offerings, (iv) the risk of downturns in demand for products using synthetic biology, (v) the uncertainty regarding the demand for passive monitoring programs and biosecurity services, (vi) changes to the biosecurity industry,
More news about: Ginkgo Bioworks
Aug 05, 2025, 11:44 ET Cell Line and Membrane Market to Grow at 12.5% CAGR Through 2030
startups: Bit.bio: Founded by the University of Cambridge, bit.bio is a human synthetic biology startup that specializes in coding cells for novel cures by using its opti-ox technology to produce scalable and reliable human cells for cell
More news about: BCC Research LLC
Jul 31, 2025, 10:15 ET Biopharmaceuticals Market is Estimated to Reach USD 948.6 Bilion by 2032 | SkyQuest Technology Consulting
Pharmaceuticals Sector: Synthetic Biology Market - https://www.skyquestt.com/report/synthetic-biology-marketInterventional Oncology Market -
More news about: SkyQuest Technology
Jul 30, 2025, 09:01 ET Ginkgo to Deploy Modular Automation Technology to the Environmental Molecular Sciences Laboratory (EMSL) at Pacific Northwest National Labs (PNNL) to Accelerate Microbial Research for the Bioeconomy
business opportunities, including with respect to our solutions and tools offerings, (iv) the risk of downturns in demand for products using synthetic biology, (v) the uncertainty regarding the demand for passive monitoring programs and biosecurity services, (vi) changes to the biosecurity industry,
More news about: Ginkgo Bioworks
Jul 30, 2025, 08:00 ET CDI Labs Launches Pan-isotype Analysis of Serum Autoantibodies to Unlock Critical New Insights Into Humoral Immunity
sequencing.About CDI Laboratories, Inc. CDI Labs is a specialized CRO and lab services proteomics company. Powered by cutting-edge synthetic biology platforms, CDI Labs has generated the world's largest collection of proteomes, and in doing so has built a team with deep proteomics bench expertise.
More news about: CDI LABORATORIES, INC.
Jul 29, 2025, 02:27 ET Tsingke Biotech Hosts 2025 Small Nucleic Acid Therapeutics Roundtable in Beijing
BEIJING, July 29, 2025 /PRNewswire/ -- Tsingke Biotech, a leading provider of synthetic biology and nucleic acid solutions, successfully hosted the 2025 Small Nucleic Acid Therapeutics Roundtable on July 26 in
More news about: Beijing Tsingke Biotech Co., Ltd.
Jul 29, 2025, 02:15 ET Tsingke Biotech Hosts 2025 Small Nucleic Acid Therapeutics Roundtable in Beijing
July 29, 2025 /PRNewswire/ -- Tsingke Biotech, a leading provider of synthetic biology and nucleic acid solutions, successfully hosted the 2025 Small Nucleic Acid Therapeutics Roundtable on July 26 in
More news about: Beijing Tsingke Biotech Co., Ltd.
Jul 24, 2025, 10:01 ET Kevin Lo Joins S2G Investments as Operating Partner
Defense Advanced Research Projects Agency (DARPA) and the U.S. Department of Defense, where he focused on advancing innovation in food security, synthetic biology, and artificial intelligence. Prior to that, he was a senior executive at Meta and Google, leading major connectivity and infrastructure programs
More news about: S2G Investments
Jul 23, 2025, 09:00 ET K18 LAUNCHES HEATBOUNCE™ -- THE FUTURE OF HEAT PROTECTION
salon-exclusive damage repair service that protects, strengthens, and preserves hair health through even extreme salon services. As the leader in synthetic biology for beauty, K18 sets itself apart by addressing hair health from the inside out, rather than relying on surface-level solutions. With over 20
More news about: K18 Biomimetic Hairscience
Jul 23, 2025, 00:40 ET Tag along with Jay at CISCE: 3, 2, 1, Go! Linking you to a better lifestyle
rice liquid, with no added water — a formulation that caught his attention. Staff further showcased the core engine behind such innovations: the synthetic biology pilot transformation platform. This critical bridge connecting labs to mass production is accelerating the transformation of research ideas into
More news about: China.org.cn
Jul 22, 2025, 10:01 ET Pharmaceutical Excipients Market worth $14.9 billion by 2030 with 6.1% CAGR | MarketsandMarkets™
Synthetic Biology Market
More news about: MarketsandMarkets
Jul 22, 2025, 09:00 ET National Organization for Rare Disorders Announces New Board Members
Research Analyst at TD Securities, where his work was concentrated on emerging life science tools and technologies such as AI-driven drug discovery, synthetic biology, and cell and gene therapy. His financial experience spans equity research and health care investment banking, advising both public and private
More news about: National Organization for Rare Disorders (NORD®)
Jul 22, 2025, 08:00 ET Codagenix Awarded PATH Subcontract to Develop Stabilized Novel Oral Polio Vaccine Candidates
Codagenix will develop nOPV-maxSD vaccine candidates with its proprietary synthetic biology to further improve genetic stability FARMINGDALE, N.Y., July
More news about: Codagenix Inc.
Jul 17, 2025, 09:01 ET Ginkgo Bioworks Launches ADME Profiling Service Using Lab Automation, Offering a US-based Operation That Will Match or Beat Pricing Quotes from Chinese or Other International Vendors
business opportunities, including with respect to our solutions and tools offerings, (iv) the risk of downturns in demand for products using synthetic biology, (v) the uncertainty regarding the demand for passive monitoring programs and biosecurity services, (vi) changes to the biosecurity industry,
More news about: Ginkgo Bioworks
Jul 16, 2025, 09:00 ET Pivot Bio Expands World-Class Scientific Advisory Board to Advance the Future of Crop Nutrition
Biotechnology, MIT; Co-founder, Pivot Bio A visionary in synthetic biology who bridges computation and life sciences, Dr. Voigt co-directs MIT's Synthetic Biology Center where he develops genetic circuits that program cells like computers. His pioneering
More news about: Pivot Bio, Inc
Jul 09, 2025, 09:00 ET CDI Labs Canada Launches Hormone-focused PhIP-Seq Library for Highly Multiplexed Analysis of Serum Autoantibodies
Ontario. About CDI Laboratories, Inc. CDI Labs is a specialized CRO and lab services proteomics company. Powered by cutting-edge synthetic biology platforms, CDI Labs has generated the world's largest collection of proteomes, and in doing so has built a team with deep proteomics bench expertise.
More news about: CDI LABORATORIES, INC.